Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products
Transplant Infectious Disease · 11.08.2026
DOI: 10.1111/tid.70296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 11.08.2026. Verfasst von Nadja Widmer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Interregional Blood Transfusion SRC, Bern, Switzerland. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Transplant Cohort Study, Humanitarian Foundation of the Swiss Red Cross.
Abstract (Originalsprache)
Background
In Switzerland, hepatitis E virus (HEV) Genotype 3 is the leading cause of acute viral hepatitis and is mainly transmitted via contaminated pork, but also through solid organ transplantation and blood transfusion. Immunocompromised patients are particularly at risk, as chronic hepatitis may develop. This nationwide cross‐sectional study aimed to retrospectively assess HEV epidemiology in SOT and allogeneic hematopoietic stem cell transplant recipients.
Methods
A total of 2942 patients from the Swiss Transplant Cohort Study sampled at transplantation date (T0) and at 1‐year follow‐up (T12) were tested for anti‐HEV IgG and HEV RNA. For seroconverted or HEV RNA‐positive patients, further analyses were performed, including characterization of samples collected 6 months posttransplantation (T6). Furthermore, 587 archived blood donor samples were retrospectively examined to investigate their potential role in HEV transmission.
Results
The anti‐HEV IgG seroprevalence of 21.6% at T0 and 19.4% at T12 in transplant recipients was comparable to that of Swiss blood donors. However, the overall incidence of HEV RNA of 1:210 was more than 20‐fold higher, with 53% of infections persisting for 6 months or more. Except for one imported genotype 1g case, all infections were of Genotype 3, predominantly subtype 3h3, which is endemic in Switzerland. Notably, a transfusion‐transmitted HEV infection was identified.
Conclusion
Given the increased susceptibility of transplant recipients to HEV and their reduced ability to clear the infection, surveillance and dietary advisory measures are crucial to reduce the risk of potentially deleterious outcomes. HEV screening of blood donors should be maintained as an important preventive measure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interregional Blood Transfusion SRC, Bern, Switzerland.
- Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.
- National Blood Transfusion Service of the Swiss Red Cross, Bern, Switzerland.
- Department of Nephrology and Transplantation Medicine, Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
- Service d'Hépato-Gastroentérologie, Hôpital Trousseau, Chambray-lès-Tours, France.
ORCID-Profile: Nadja Widmer, Beat Müllhaupt, Urs Schanz, Soraya Amar, Laure Elkrief, Cédric Hirzel, Darius Moradpour, Nicolas J Mueller, Stefan Schaub, Guido Stirnimann, Julien Vionnet, Christoph Niederhauser
Förderung
- Swiss Transplant Cohort Study
- Humanitarian Foundation of the Swiss Red Cross
Zitieren
APA
Widmer, N., Gowland, P., Müllhaupt, B., Schanz, U., Amar, S., Binet, I., Jaspersen, A., Elkrief, L., Hirsch, H. H., Hirzel, C., Moradpour, D., Mueller, N. J., Rossi, S., Schaub, S., Stirnimann, G., Stolz, M., Van Delden, C., Vionnet, J., Niederhauser, C., & Swiss Transplant Cohort Study (2026). Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products. Transplant Infectious Disease. https://doi.org/10.1111/tid.70296
Vancouver
Widmer N, Gowland P, Müllhaupt B, Schanz U, Amar S, Binet I, et al. Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products. Transplant Infectious Disease. 2026. doi:10.1111/tid.70296
BibTeX
@article{Widmer2026,
author = {Widmer, Nadja and Gowland, Peter and Müllhaupt, Beat and Schanz, Urs and Amar, Soraya and Binet, Isabelle and Jaspersen, Aylin and Elkrief, Laure and Hirsch, Hans H and Hirzel, Cédric and Moradpour, Darius and Mueller, Nicolas J and Rossi, Simona and Schaub, Stefan and Stirnimann, Guido and Stolz, Martin and Van Delden, Christian and Vionnet, Julien and Niederhauser, Christoph and Swiss Transplant Cohort Study, Swiss Transplant Cohort Study},
title = {Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70296}
}
EUVIMED